174 related articles for article (PubMed ID: 24844357)
1. Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma.
Glitza IC; Lu G; Shah R; Bashir Q; Shah N; Champlin RE; Shah J; Orlowski RZ; Qazilbash MH
Leuk Lymphoma; 2015 Mar; 56(3):602-7. PubMed ID: 24844357
[TBL] [Abstract][Full Text] [Related]
2. Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma.
Abdallah N; Baughn LB; Rajkumar SV; Kapoor P; Gertz MA; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Go RS; Hwa YL; Fonder A; Hobbs M; Lin Y; Leung N; Kourelis T; Warsame R; Siddiqui M; Lust J; Kyle RA; Ketterling R; Bergsagel L; Greipp P; Kumar SK
Clin Cancer Res; 2020 Dec; 26(24):6581-6588. PubMed ID: 33008815
[TBL] [Abstract][Full Text] [Related]
3. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K
Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914
[TBL] [Abstract][Full Text] [Related]
4. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
5. Myc rearrangement redefines the stratification of high-risk multiple myeloma.
Jin X; Li H; Zhang D; Liu S; Song Y; Zhang F; Li Z; Zhuang J
Cancer Med; 2024 Jun; 13(11):e7194. PubMed ID: 38845529
[TBL] [Abstract][Full Text] [Related]
6. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
[TBL] [Abstract][Full Text] [Related]
7. Appraising myc involvement in high risk myeloma.
Kastritis E; Dimopoulos MA
Leuk Lymphoma; 2015 Mar; 56(3):551-2. PubMed ID: 25257347
[No Abstract] [Full Text] [Related]
8. Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma.
Szabo AG; Gang AO; Pedersen MØ; Poulsen TS; Klausen TW; Nørgaard P
Leuk Lymphoma; 2016 Nov; 57(11):2526-34. PubMed ID: 27243588
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for diffuse large B-cell lymphoma having 8q24/MYC rearrangement in Japan.
Takahashi T; Suzuki R; Yamamoto G; Nakazawa H; Kurosawa M; Kobayashi T; Okada M; Akasaka T; Kim SW; Fukuda T; Ichinohe T; Atsuta Y; Suzumiya J
Hematol Oncol; 2021 Feb; 39(1):66-74. PubMed ID: 32979280
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
[TBL] [Abstract][Full Text] [Related]
11. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
[TBL] [Abstract][Full Text] [Related]
12. c-myc overexpression is not mandatory in aggressive-phase multiple myeloma with Burkitt's type translocation.
Kuroda J; Kimura S; Akaogi T; Hayashi H; Nishida K; Taniwaki M; Kashima K; Abe T; Kobayashi Y; Kondo M
Ann Hematol; 2000 Sep; 79(9):514-8. PubMed ID: 11043423
[TBL] [Abstract][Full Text] [Related]
13. The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
Jin Y; Yu X; Du J; Li H; Tang W; Jia C; Zan Y; Chen M; Zhang Y; Yu M; Rong W; Zhou D; Zhuang J
Ann Hematol; 2021 May; 100(5):1251-1260. PubMed ID: 33686491
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
15. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
16. Frequent upregulation of MYC in plasma cell leukemia.
Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
[TBL] [Abstract][Full Text] [Related]
17. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
[TBL] [Abstract][Full Text] [Related]
18. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms.
Boddu PC; Wang SA; Pemmaraju N; Tang Z; Hu S; Li S; Xu J; Medeiros LJ; Tang G
Leuk Res; 2018 Mar; 66():73-78. PubMed ID: 29407586
[TBL] [Abstract][Full Text] [Related]
19. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
[TBL] [Abstract][Full Text] [Related]
20. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
